Screening for newborn fatty acid oxidation disorders in Chongqing and the follow-up of confirmed children.

Abstract

OBJECTIVE:

To investigate the incidence, clinical characteristics, gene mutations and prognosis of fatty acid oxidation disorders (FAOD) in newborns in Chongqing.

METHODS:

Blood samples were collected from 35 374 newborns for screening of FAOD in the Neonatal Screening Center of Women and Children's Hospital of Chongqing Medical University from July 2020 to February 2022. The acylcarnitine spectrum was detected by tandem mass spectrometry, the positive children in primary screening were recalled within 2 weeks, and the diagnosis of FAOD was confirmed by urine organic acid measurement, blood biochemistry testing and genetic analysis. The confirmed children were given early intervention, treatment and followed-up.

RESULTS:

Among 35 374 newborns, there were 267 positive children in primary screening, with a positive rate of 0.75%. Five children with FAOD were diagnosed by gene detection, with an incidence rate of 1/7075. Among them, there were 3 cases of primary carnitine deficiency (PCD, 1/11 791), 1 case of short-chain acyl-CoA dehydrogenase deficiency (SCADD, 1/35 374) and 1 case of very long-chain acyl-CoA dehydrogenase deficiency (VLCADD, 1/35 374). The c.1400C>G and c.338G>A were the common mutations of SLC22A5 gene in 3 children with PCD, while c.621G>T was a novel mutation. There were no clinical manifestations during the follow-up period in 2 children with supplementation of L-carnitine. Another child with PCD did not follow the doctor's advice of L-carnitine treatment, and had acute attack at the age of 6 months. The child recovered after treatment, and developed normally during the follow-up. The detected ACADS gene mutations were c.417G>C and c.1054G>A in child with SCADD, who showed normal intelligence and physical development without any clinical symptoms. The mutations of ACADVL gene were c.1349G>A and c.1843C>T in child with VLCADD, who showed acute attack in the neonatal period and recovered after treatment; the child was fed with milk powder rich in medium-chain fatty acids and had normal development during the follow-up.

CONCLUSIONS:

The incidence of FAOD in Chongqing area is relatively high. PCD is the most common type, and the clinical phenotype of VLCADD is serious. After early diagnosis through neonatal screening, standardized treatment and management is followed, most of FAOD children can have good prognosis.

• Authors: Min Chen, Yifan Yin, Hao Liu, Yong Peng, Liang Ye, Qian Luo, Jingkun Miao
• Journal: Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences (Zhejiang Da Xue Xue Bao Yi Xue Ban) Vol. 51 Issue 3 Pg. 290-297 (Jun 25 2022) ISSN: 1008-9292 [Print] China
• PMID: 36207828 (Publication Type: Journal Article)

Chemical References

• Fatty Acids
• Powders
• SLC22A5 protein, human
• Solute Carrier Family 22 Member 5
• Carnitine

Topics

• Carnitine
• Fatty Acids
• Female
• Follow-Up Studies
• Humans
• Infant, Newborn
• Lipid Metabolism, Inborn Errors (diagnosis, epidemiology, genetics)
• Mutation
• Neonatal Screening
• Powders
• Solute Carrier Family 22 Member 5 (genetics)